KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Aurinia Pharmaceuticals (AUPH) Other Gross PP&E Adjustments (2016 - 2026)

Aurinia Pharmaceuticals filings provide 9 years of Other Gross PP&E Adjustments readings, the most recent being -$6.1 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 92.93% to -$6.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.1 million, a 92.93% increase, with the full-year FY2025 number at -$6.1 million, up 92.93% from a year prior.
  • Other Gross PP&E Adjustments hit -$6.1 million in Q4 2025 for Aurinia Pharmaceuticals, up from -$73.5 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $5.1 million in Q4 2022 to a low of -$107.8 million in Q3 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$212500.0 (2021), compared with a mean of -$26.9 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 4057.36% in 2022 and later crashed 88476.23% in 2023.
  • Aurinia Pharmaceuticals' Other Gross PP&E Adjustments stood at -$129000.0 in 2021, then surged by 4057.36% to $5.1 million in 2022, then plummeted by 2126.46% to -$103.5 million in 2023, then grew by 16.09% to -$86.8 million in 2024, then soared by 92.93% to -$6.1 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$6.1 million (Q4 2025), -$73.5 million (Q3 2025), and -$77.9 million (Q2 2025) per Business Quant data.